Diclofenac Epolamine System
Product Images NDC 76420-673

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Diclofenac Epolamine (NDC 76420-673). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Asclemed Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Diclofenac 01)

Chemical Structure (Diclofenac 01)
Chemical structure of Diclofenac Epolamine showing the Diclofenac moiety with chlorinated aromatic rings and the Epolamine moiety identified as 2-(pyrrolidin-1-yl)ethanol.*
FDA Label Image

Figure 1 (Diclofenac 02)

Figure 1 (Diclofenac 02)
A line graph comparing the percent improvement from baseline against the percent of patients improved for Diclofenac Patch and Placebo. The graph shows two lines, with the Diclofenac Patch consistently having a higher percent of patients improved across the range of percent improvement values.*
FDA Label Image

Figure 2 (Diclofenac 03)

Figure 2 (Diclofenac 03)
A line graph comparing the percent of patients improved over varying percent improvements from baseline for Diclofenac Patch versus Placebo. Diclofenac Patch shows higher patient improvement percentages consistently across all ranges compared to Placebo.*
FDA Label Image

Figure 3 (Diclofenac 04)

Figure 3 (Diclofenac 04)
A line graph comparing the percent of patients improved versus percent improvement from baseline for Diclofenac Patch and placebo. The graph shows two plotted lines with symbols representing Diclofenac Patch and placebo, illustrating patient improvement rates.*
FDA Label Image

Figure 4 (Diclofenac 05)

Figure 4 (Diclofenac 05)
A line graph comparing percent improvement from baseline to percent of patients improved for Diclofenac Patch versus Placebo. The x-axis represents percent improvement from baseline, and the y-axis shows the percent of patients improved. The Diclofenac Patch consistently demonstrates a higher percentage of patients improved across increasing levels of improvement compared to Placebo.*
FDA Label Image

Carton-box (Diclofenac 06)

Carton-box (Diclofenac 06)
Label for Diclofenac Epolamine topical system 1.3%, a prescription topical system by Asclemed USA, Inc. The label shows a package quantity of 30 units, NDC 76420-673-30, with details on distribution by Yaral Pharma, Inc., lot and batch numbers, and storage instructions. The label includes a QR code and cautions about prescription requirements and child safety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.